Cysteamine

DRUG11 trials

Sponsors

Katagiri Daisuke, National Eye Institute (NEI), Mylan Laboratories, National Human Genome Research Institute (NHGRI), Joel Lavine

Conditions

Community-acquired Pneumonia, Influenza, COVID-19Corneal Cystine CrystalsCystic FibrosisCystinosisCystinosis CystinosisFatty LiverHIV InfectionsNephropathic Cyctinosis

Phase 1

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

CompletedNCT00001736

National Eye Institute (NEI)Cystinosis

Start: 1998-05-31End: 2001-03-31Target: 51Updated: 2008-03-04

A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)

CompletedNCT00799578

Joel LavineFatty Liver

Start: 2008-10-31End: 2010-01-31Updated: 2014-01-31

First Study of Oral Cysteamine in Cystic Fibrosis

CompletedNCT02212431

University of AberdeenCystic Fibrosis

Start: 2014-08-31End: 2015-04-30Updated: 2015-11-05

Single-dose Trial of Enteric-coated Cysteamine Bitartrate Capsules in Healthy Adults

RecruitingJPRN-jRCTs031240346

Katagiri DaisukeCystinosis Cystinosis

Start: 2024-11-28Target: 10Updated: 2025-07-18

Phase 2

Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis

CompletedNCT00001213

National Eye Institute (NEI)Cystinosis

Start: 1986-04-30End: 2013-07-31Updated: 2014-07-22

A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease

CompletedNCT00002110

Mylan LaboratoriesHIV Infections

Target: 300Updated: 2005-06-24

A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations

CompletedNCT03000348

NovaBiotics Ltd.Cystic Fibrosis

Start: 2016-12-31End: 2018-04-30Updated: 2021-04-14

Effectiveness of a Bilayering Serum and Cream Containing GABA, DMAE, Cysteamine, and Bakuchiol for Skin Whitening and Anti-Aging

CompletedNCT07477288

Hasanuddin UniversitySkin Aging

Start: 2025-03-12End: 2025-12-29Updated: 2026-03-24

Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

RecruitingNCT02735707

UMC UtrechtCommunity-acquired Pneumonia, Influenza, COVID-19

Start: 2016-04-11End: 2028-02-29Target: 20000Updated: 2024-07-12

Unknown Phase

Use of Cysteamine in the Treatment of Cystinosis

RecruitingNCT00359684

National Human Genome Research Institute (NHGRI)Cystinosis

Start: 1979-01-04Target: 330Updated: 2026-03-24

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

CompletedNCT02766855

The Eye Center and The Eye Foundation for Research in OphthalmologyCorneal Cystine Crystals, Nephropathic Cyctinosis

Start: 2004-01-31End: 2016-03-31Updated: 2016-05-10

Related Papers

Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial

Thorax2025-05-139 citations

Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia

Intensive Care Medicine2025-04-0132 citations

A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial.

2023-12-068 citations

Simvastatin in Critically Ill Patients with Covid-19

New England Journal of Medicine2023-10-2559 citations

Intravenous Vitamin C for Patients Hospitalized With COVID-19

JAMA2023-10-2545 citations

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19

JAMA2023-04-1166 citations

The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors

The Journal of Infectious Diseases2023-03-274 citations

Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19

JAMA2023-03-2192 citations

The Impact of COVID-19 Research on the Development of Scalable Frameworks for Efficient Clinical Trials in Cardiovascular Medicine

Canadian Journal of Cardiology2023-03-153 citations

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.

2022-12-0128 citations

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.

2022-09-2211 citations

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

JAMA2022-03-22144 citations

Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial

BMJ2022-01-0779 citations

Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID‐19: Insights from the HOPE COVID‐19 Registry

International Journal of Clinical Practice2022-01-015 citations

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19

JAMA2021-10-05208 citations

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Bristol Research (University of Bristol)2021-08-26586 citations

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

New England Journal of Medicine2021-08-041046 citations

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

New England Journal of Medicine2021-08-04947 citations

Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19.

2021-07-197 citations

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk

BMJ Open2021-06-0127 citations

7 more papers not shown